Abstract
Coronavirus disease 2019 (COVID-19) is a novel human respiratory disease caused by the SARS-CoV-2 virus. Asymptomatic carriers of the COVID-19 virus display no clinical symptoms but are known to be contagious. Recent evidence reveals that this sub-population, as well as persons with mild disease, are a major contributor in the propagation of the disease. The fast spread of COVID-19 forced governments around the world to establish and enforce generalized lockdowns, geared towards minimizing community transmission. This created an unprecedented epidemiological situation not properly characterized by existing mathematical models of isolation and quarantine. In this manuscript, we present a mathematical model for community transmission of COVID-19 taking into account asymptomatic carriers during the lockdown period. The main results consist of an exact calculation of the effective reproduction number 
, and a modeling framework that enables the quantification of generalized lockdowns on community transmission. A computation of 
is provided, assuming mean parameters. The first three weeks of the model exhibit exponential growth, which is in agreement with average case data collected from thirteen countries with universal health care and robust communicable disease surveillance systems. The point estimate of the basic reproduction number is 
.
Competing Interest Statement
The authors have declared no competing interest.
Funding Statement
N/A
Author Declarations
All relevant ethical guidelines have been followed; any necessary IRB and/or ethics committee approvals have been obtained and details of the IRB/oversight body are included in the manuscript.
Yes
All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.
Yes
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Yes
I have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.
Yes
Footnotes
This version includes considerations for mitigation strategies. We introduced a coefficient, labeled k, named the "risk mitigation coefficient". The mathematical formulation was expanded to account for this coefficient. The model can now be used to study a broad swath of mitigation strategies ranging from shelter-in-pace orders to guidelines for social interaction.
Data Availability
All data used in this article is available from public sources.
